Featured

Investors show interest in Article 9 continuation funds

Impact investor Summa Equity closed Summa Circular, believed to be the first Article 9 continuation fund, in December, breaking new ground for the secondaries market.

GP-leds: The price is right

Sponsors and management teams need to demonstrate their commitment to the next phase of growth.

China Life (Taiwan) commits $40m to StepStone Secondary Opportunities Fund V

The Taiwan-based insurance company has backed an private equity secondaries fund.

Fubon Life commits $70m to Strategic Partners Infrastructure IV

The Taiwan-based insurance company has backed an infrastructure secondaries fund.

The Secondaries Investor 50 – fundraisers belie difficult 2023

Our ranking of the biggest secondaries fundraisers reveals a market reaching an inflection point.

Do GPs need to hire a third party to obtain a valuation and fairness opinion in a GP-led?

Proposed reforms in the US aim to make an independent fairness opinion a requirement in GP-led deals.

Do LPs need to conduct due diligence if they are rolling over exposure to a continuation fund?

Decision-making can be a resource-intensive process, although it is one that LPs are becoming more familiar with.

The secondaries market’s top five people moves of 2022

A round up of some the most noteworthy appointments from last year, as the secondaries market continued its game of recruitment musical chairs.

How LPs are weighing up continuation fund opportunities

PEI’s annual investor survey indicates that LPs aren’t rushing to exit every deal, but they do expect third-party valuations.

How much does it cost to run a GP-led process and who pays?

The parties that bear the costs can vary according to the structure of the deal.